- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 01.04. | G MEDICAL INNOVATIONS HOLDINGS LIMITED: Units Outstanding & Other Information as at 31 March 2024 | - | ASX | ||
| 07.03. | G MEDICAL INNOVATIONS HOLDINGS LIMITED: Units Outstanding & Other Information as at 29 Feb 2024 | 1 | ASX | ||
| 05.03. | G MEDICAL INNOVATIONS HOLDINGS LIMITED: Indicative dividends calendar for 2024 | - | ASX | ||
| 27.02. | G MEDICAL INNOVATIONS HOLDINGS LIMITED: Product Disclosure Statement | - | ASX | ||
| 27.02. | G MEDICAL INNOVATIONS HOLDINGS LIMITED: Admission and Commencement of Trading - GMVW | - | ASX | ||
| 18.12.23 | G Medical Innovations Holdings Ltd. - 6-K, Report of foreign issuer | 4 | SEC Filings | ||
| 29.11.23 | G Medical Innovations Holdings Ltd. - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 11.10.23 | Delisting of Securities of Humanigen, Inc.; Vinco Ventures, Inc.; Liquid Media Group Ltd.; Republic First Bancorp, Inc.; G Medical Innovations Holdings Ltd.; Orbital Infrastructure Group, Inc.; Spark Networks SE; DIRTT Environmental Solutions Ltd.; Chengh | 561 | GlobeNewswire (Europe) | NEW YORK, Oct. 11, 2023 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock of Humanigen, Inc. Humanigen, Inc.'s securities were suspended on July 26,... ► Artikel lesen | |
| 05.09.23 | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 05.09.2023 | 542 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 05.09.2023Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 05.09.2023ISIN NameIT0005421646 LABOMAR... ► Artikel lesen | |
| 07.08.23 | G Medical Innovations Holdings Ltd.: G Medical Innovations' CEO Issues Update to Shareholders, August 2023 | 329 | GlobeNewswire (Europe) | Rehovot, Israel, Aug. 07, 2023 (GLOBE NEWSWIRE) -- G Medical Innovations Holdings Ltd. (Nasdaq: GMVD) ("G Medical Innovations" or the "Company"), a global leader in next-generation mobile health (mHealth)... ► Artikel lesen | |
| 19.05.23 | G Medical Innovations Holdings Ltd. Announces Receipt of Nasdaq Minimum Bid Price Notification | 592 | GlobeNewswire (Europe) | Rehovot, Israel, May 19, 2023 (GLOBE NEWSWIRE) -- G Medical Innovations Holdings Ltd. (Nasdaq: GMVD) (the "Company"), a telehealth, medical device, and remote patient monitoring company, announced... ► Artikel lesen |
11 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| TELADOC HEALTH | 12,410 | -0,67 % | Teladoc Health kann Umsatz leicht steigern, Verlust aber erhöht sich | PURCHASE, New York (IT-Times) - Teladoc Health hat seine Ergebnisse für das Auftaktquartal des Geschäftsjahres 2024/2025 veröffentlicht und ein kleines Wachstum verzeichnet. Teladoc Aktie: QuartalsergebnisTeladoc... ► Artikel lesen | |
| BICO GROUP | 4,022 | -0,35 % | UNGLAUBLICHE Sondermeldung bei Bico Group Aktie: DAS erwischt Anleger heute eiskalt. Dringend lesen und reagieren! | ||
| DEXCOM | 116,66 | -0,58 % | DexCom Aktie: Umsatzwachstum Trotz Insiderverkäufe | DexCom, ein Unternehmen im Bereich der Medizintechnologie, das fortlaufende Glukose-Monitoring-Systeme entwickelt, hat eine positive Umsatzprognose für das bevorstehende Quartal veröffentlicht. Die... ► Artikel lesen | |
| HIMS & HERS HEALTH | 11,715 | +0,09 % | Hims & Hers Health, Inc. - 8-K, Current Report | ||
| NUGEN MEDICAL DEVICES | 0,075 | -1,31 % | Nugen Medical Devices Inc: Nugen Medical two million shares for debt | ||
| PLUS THERAPEUTICS | 1,558 | +1,70 % | Plus Therapeutics Inc.: Neuro-Oncologist Andrew Brenner, M.D., Ph.D. and Barbara Blouw, Ph.D. Join Plus' Management Team | The addition of both Dr. Brenner and Dr. Blouw substantially expands Plus internal expertise in key areas Dr. Brenner will maintain his academic commitments but will greatly contribute to Plus' scientific... ► Artikel lesen | |
| INVITAE | 0,110 | 0,00 % | Labcorp Wins Bid To Acquire Invitae Assets For $239 Mln Plus Non-Cash Considerations | WASHINGTON (dpa-AFX) - Invitae said that Labcorp (LH) has emerged as the successful bidder in the company's auction during its sale process under Section 363 of the U.S. Bankruptcy Code. Labcorp... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 1,444 | +1,40 % | Atossa Therapeutics, Inc.: Atossa Therapeutics Announces Expanded Research Agreement with Weill Cornell Medicine to Further Evaluate Synergy Between Antibody Drug Conjugates (ADCs) and (Z)-Endoxifen | SEATTLE, April 29, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company") today announced an expanded research agreement with Weill Cornell Medicine to explore... ► Artikel lesen | |
| EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc.: Evofem Reports $18.2 million of Phexxi Net Product Sales in 2023 | -- Third Consecutive Year of Phexxi Net Sales Growth --
-- Total Operating Expense Reduced 64% from 2022 Levels --
-- Sales and marketing expense as a percentage of net sales was 54% for the fourth... ► Artikel lesen | |
| SONOMA PHARMACEUTICALS | 0,137 | -0,58 % | Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Announces Expansion of Negative-Pressure Wound Therapy Products for Use in the United States | BOULDER, CO / ACCESSWIRE / April 9, 2024 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous... ► Artikel lesen | |
| ORPEA | 13,634 | +0,19 % | EMEIS PURSUES ITS REFOUNDATION: 2023 Consolidated Financial Results of ORPEA S.A. | Significant improvement in non-financial indicators, with major advances for employees, residents and patients
Health and safety: decline in the work-related accident frequency rate, at 24.8... ► Artikel lesen | |
| ASENSUS SURGICAL | 0,224 | -4,28 % | Asensus Surgical, Inc.: Asensus Surgical Announces Sendai Tokushukai Hospital in Japan to Initiate Senhance Surgery Program | ||
| INVIVO THERAPEUTICS HOLDINGS | 0,328 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 23.02.2024 | The following instruments on Boerse Frankfurt do have their last trading day on 23.02.2024.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 23.02.2024.ISIN NameCA58503M4083 MEDIVOLVE... ► Artikel lesen | |
| HEALWELL AI | 1,045 | +1,46 % | wO Börsenlounge: Adidas, Mercedes, HealWELL AI - DroneShield zieht nach Zahlen gut an! | Die Aktie des australischen Spezialisten für die Abwehr von Drohnen zieht zweistellig an. Grund sind gute Zahlen für das erste Quartal des Jahres. Wie viel Potenzial hat der Pennystock aus Down Under... ► Artikel lesen | |
| CYTOSORBENTS | 0,750 | -1,70 % | CytoSorbents to Report First Quarter 2024 Operating and Financial Results |
G MEDICAL INNOVATIONS HOLDINGS LTD gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 0,068 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
